Clinical Trial Detail

NCT ID NCT03477864
Title Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer
Recruitment Withdrawn
Gender male
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Cancer Center at Thomas Jefferson University
Indications

prostate cancer

Therapies

Ipilimumab

Cemiplimab + Ipilimumab

Cemiplimab

Age Groups: senior adult

No variant requirements are available.